171 related articles for article (PubMed ID: 24595237)
1. Effect of NK4 transduction in bone marrow-derived mesenchymal stem cells on biological characteristics of pancreatic cancer cells.
Sun YP; Zhang BL; Duan JW; Wu HH; Wang BQ; Yu ZP; Yang WJ; Shan YF; Zhou MT; Zhang QY
Int J Mol Sci; 2014 Mar; 15(3):3729-45. PubMed ID: 24595237
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
[TBL] [Abstract][Full Text] [Related]
3. The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer.
Cai C; Hou L; Zhang J; Zhao D; Wang Z; Hu H; He J; Guan W; Ma Y
Appl Biochem Biotechnol; 2017 Sep; 183(1):444-459. PubMed ID: 28353041
[TBL] [Abstract][Full Text] [Related]
4. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
Lai RX; Yuan SZ; Nakamura T
Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.
Yasui T; Ohuchida K; Zhao M; Cui L; Onimaru M; Egami T; Fujita H; Ohtsuka T; Mizumoto K; Matsumoto K; Tanaka M
Anticancer Res; 2011 Apr; 31(4):1279-87. PubMed ID: 21508376
[TBL] [Abstract][Full Text] [Related]
7. Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet.
Manabe T; Mizumoto K; Nagai E; Matsumoto K; Nakamura T; Nukiwa T; Tanaka M; Matsuda T
Clin Cancer Res; 2003 Aug; 9(8):3158-66. PubMed ID: 12912968
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
[TBL] [Abstract][Full Text] [Related]
9. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
Egami T; Ohuchida K; Miyoshi K; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
Cancer Sci; 2009 Apr; 100(4):722-9. PubMed ID: 19302285
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
[TBL] [Abstract][Full Text] [Related]
12. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
[TBL] [Abstract][Full Text] [Related]
13. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
[TBL] [Abstract][Full Text] [Related]
14. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Anesthetics Enhance the Ability of Human Bone Marrow-Derived Mesenchymal Stem Cells to Alleviate Hepatic Ischemia-Reperfusion Injury in a Receptor-Dependent Manner.
Feng J; Yao W; Zhang Y; Xiang AP; Yuan D; Hei Z
Cell Physiol Biochem; 2018; 47(2):556-566. PubMed ID: 29794450
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.
Egami T; Ohuchida K; Yasui T; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
Cancer Sci; 2009 Oct; 100(10):1902-7. PubMed ID: 19604247
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]